Host-Parasite Interaction Biology Group, National Institute of Malaria Research, Indian Council of Medical Research, Sector-8, Dwarka, New Delhi 110 077, India.
J Trop Med. 2012;2012:345195. doi: 10.1155/2012/345195. Epub 2012 Feb 19.
Evidence indicates that cysteine proteases play essential role in malaria parasites; therefore an obvious area of investigation is the inhibition of these enzymes to treat malaria. Studies with cysteine protease inhibitors and manipulating cysteine proteases genes have suggested a role for cysteine proteases in hemoglobin hydrolysis. The best characterized Plasmodium cysteine proteases are falcipains, which are papain family enzymes. Falcipain-2 and falcipain-3 are major hemoglobinases of P. falciparum. Structural and functional analysis of falcipains showed that they have unique domains including a refolding domain and a hemoglobin binding domain. Overall, the complexes of falcipain-2 and falcipain-3 with small and macromolecular inhibitors provide structural insight to facilitate the design or modification of effective drug treatment against malaria. Drug development targeting falcipains should be aided by a strong foundation of biochemical and structural studies.
证据表明半胱氨酸蛋白酶在疟原虫中发挥着重要作用;因此,一个明显的研究领域是抑制这些酶来治疗疟疾。对半胱氨酸蛋白酶抑制剂和操纵半胱氨酸蛋白酶基因的研究表明,半胱氨酸蛋白酶在血红蛋白水解中起作用。最具特征的恶性疟原虫半胱氨酸蛋白酶是木瓜蛋白酶家族的酶,即裂殖体蛋白。裂殖体蛋白-2 和裂殖体蛋白-3 是恶性疟原虫的主要血红蛋白酶。裂殖体蛋白的结构和功能分析表明,它们具有独特的结构域,包括折叠域和血红蛋白结合域。总之,裂殖体蛋白-2 和裂殖体蛋白-3 与小分子和大分子抑制剂的复合物提供了结构上的深入了解,有助于设计或修饰针对疟疾的有效药物治疗。针对裂殖体蛋白的药物开发应该得到生化和结构研究的坚实基础的帮助。